Skip to main content
Clinical Trials/NCT05011500
NCT05011500UnknownNot Applicable

Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC Study)

Cancer Research Antwerp1 site in 1 country24 target enrollmentStarted: June 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
24
Locations
1
Primary Endpoint
Positional Deviation

Study Overview

Brief Summary

The purpose of this study is to investigate the feasibility of using open masks or no masks in combination with optical surface scanning for radiotherapy in patients with head and neck cancer.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients ≥ 18 years old
  • •Histologically confirmed head and neck cancer.
  • •Patients treated with radiotherapy (RT) as primary treatment.
  • •An Eastern Cooperative Oncology Group (ECOG) Performance Status grade of 0-1 as defined in Appendix
  • •Each subject must sign an informed consent form (ICF) indicating that he understands the purpose of and procedures required for the study and is willing to participate in the study.
  • •Patients must be willing to comply with treatment plan and other study procedures

Exclusion Criteria

  • •Patients with significantly altered mental status or with psychological, familial, sociological or geographical condition potentially hampering compliance with the study.
  • •Patients who cannot stay still during fraction because of a disorder (e.g. Parkinson's disease)

Arms & Interventions

Starting with closed mask

Experimental

Patient 1-8, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using a closed mask. For the next 5 fractions these patients will receive radiotherapy using an open mask. For the 5 fractions after that these patients will receive radiotherapy using no mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with Closed Mask (Radiation)

Starting with closed mask

Experimental

Patient 1-8, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using a closed mask. For the next 5 fractions these patients will receive radiotherapy using an open mask. For the 5 fractions after that these patients will receive radiotherapy using no mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with Open Mask and Surface Scanning (Radiation)

Starting with closed mask

Experimental

Patient 1-8, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using a closed mask. For the next 5 fractions these patients will receive radiotherapy using an open mask. For the 5 fractions after that these patients will receive radiotherapy using no mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with No Mask (Radiation)

Starting with open mask

Experimental

Patient 9-16, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using an open mask. For the next 5 fractions these patients will receive radiotherapy using no mask. For the 5 fractions after that these patients will receive radiotherapy using a closed mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with Closed Mask (Radiation)

Starting with open mask

Experimental

Patient 9-16, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using an open mask. For the next 5 fractions these patients will receive radiotherapy using no mask. For the 5 fractions after that these patients will receive radiotherapy using a closed mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with Open Mask and Surface Scanning (Radiation)

Starting with open mask

Experimental

Patient 9-16, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using an open mask. For the next 5 fractions these patients will receive radiotherapy using no mask. For the 5 fractions after that these patients will receive radiotherapy using a closed mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with No Mask (Radiation)

Starting with no mask

Experimental

Patient 17-24, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using no mask. For the next 5 fractions these patients will receive radiotherapy using a closed mask. For the 5 fractions after that these patients will receive radiotherapy using an open mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with Closed Mask (Radiation)

Starting with no mask

Experimental

Patient 17-24, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using no mask. For the next 5 fractions these patients will receive radiotherapy using a closed mask. For the 5 fractions after that these patients will receive radiotherapy using an open mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with Open Mask and Surface Scanning (Radiation)

Starting with no mask

Experimental

Patient 17-24, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using no mask. For the next 5 fractions these patients will receive radiotherapy using a closed mask. For the 5 fractions after that these patients will receive radiotherapy using an open mask. This schedule repeats for the rest of their treatment.

Intervention: Radiotherapy with No Mask (Radiation)

Outcomes

Primary Outcomes

Positional Deviation

Time Frame: Positional Deviation will be assessed from start of treatment period to end of treatment period (up to 7 weeks).

Patient positioning and movement during treatment will be assessed using cone-beam computed tomopgraphy (CBCT). The position of the patient and target volumes measured by CBCT will be compared to computed tomography (CT) scans made during the initial simulation of treatment. CBCT-scans are made right before administering radiation and after radiation has been administered. Translational and rotational deviations will be measured and expressed in millimeters (for translational deviation) and degrees (for rotational deviation).

Secondary Outcomes

  • Radiation Dose(Radiation dose will be assessed from start of treatment period to end of treatment period (up to 7 weeks).)
  • Patient Distress(Patient distress will be assessed from start of treatment period to end of treatment period (up to 7 weeks).)
  • Duration of Treatment(Duration of treatment will be assessed from start of treatment period to end of treatment period (up to 7 weeks).)
  • Radiotherapy Technician Satisfaction(Radiotherapy technician satisfaction will be assessed from start of treatment period to end of treatment period (up to 7 weeks).)

Investigators

Sponsor
Cancer Research Antwerp
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials